Literature DB >> 2109030

Interconversion of prebeta-migrating lipoproteins containing apolipoprotein A-I and HDL.

B Y Ishida1, D Albee, B Paigen.   

Abstract

Mouse plasma from strains C57BL/6J and C3H/HeJ includes a high density lipoprotein (HDL) fraction containing apolipoprotein A-I which migrates in the prebeta region upon agarose gel electrophoresis, similar to the prebeta HDL previously reported in humans. This prebeta A-I lipoprotein species has a buoyant density of 1.080-1.210 g/ml and has two molecular weight species, 65,000 and 71,000. It is lipid-poor and deficient in apolipoprotein E. When mice are fed a high fat and high cholesterol diet, the quantity of prebeta A-I increases in both strains as determined by quantitative densitometry of agarose gel immunoblots. Prebeta A-I species are highly unstable in plasma at 37 degrees C. Initially (0-1 h) levels decreased and with further incubation (1-8 h) levels increased. Nondenaturing polyacrylamide gel electrophoresis (PAGE) demonstrated that the prebeta HDL formed during prolonged incubation (1-8 h) was identical in size to HDL in unincubated samples. The initial decrease of prebeta HDL observed during the first hour of incubation, phase I, was inhibited by DTNB, suggesting that phase I is dependent on lecithin:cholesterol acyltransferase (LCAT); however, the subsequent increase, phase II, was unaffected by DTNB and appears LCAT-independent. The prebeta A-I species formed in plasma containing DTNB after a 4-h incubation resulted in a polydisperse particle size distribution. The two strains, the atherosclerosis-susceptible C57BL/6 and -resistant C3H, displayed a similar elevation and induction of prebeta HDL during a dietary switch from laboratory chow to an atherogenic diet with a transient peak occurring at 7 days even when total HDL in the susceptible strain was greatly reduced.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109030

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid.

Authors:  Norman E Miller; Waldemar L Olszewski; Hiroaki Hattori; Irina P Miller; Takeshi Kujiraoka; Tomoichiro Oka; Tadao Iwasaki; M Nazeem Nanjee
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-11       Impact factor: 4.310

2.  Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.

Authors:  B Trigatti; H Rayburn; M Viñals; A Braun; H Miettinen; M Penman; M Hertz; M Schrenzel; L Amigo; A Rigotti; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice.

Authors:  Shuang Chen; Kenichi Shimada; Wenxuan Zhang; Ganghua Huang; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2010-10-08       Impact factor: 5.422

4.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

Authors:  E M Rubin; B Y Ishida; S M Clift; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

5.  Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.

Authors:  X Jiang; O L Francone; C Bruce; R Milne; J Mar; A Walsh; J L Breslow; A R Tall
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

6.  Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Elena Y Boudyguina; Soon-Kyu Chung; Thomas L Smith; Perry L Colvin; Xian-Cheng Jiang; John S Parks
Journal:  J Lipid Res       Date:  2008-06-25       Impact factor: 5.922

Review 7.  The role of sphingosine-1-phosphate in endothelial barrier function.

Authors:  Brent A Wilkerson; Kelley M Argraves
Journal:  Biochim Biophys Acta       Date:  2014-07-05

8.  Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.

Authors:  O L Francone; E L Gong; D S Ng; C J Fielding; E M Rubin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs.

Authors:  Yannan Zhao; Tomohiro Imura; Luke J Leman; Linda K Curtiss; Bruce E Maryanoff; M Reza Ghadiri
Journal:  J Am Chem Soc       Date:  2013-08-26       Impact factor: 15.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.